CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplant for Malignant Disease
CD34 Stem Cell Selection for Malignant Condition
Sponsor: Investigator initiated study
Enrolling: Male and Female Patients
IRB Number: AAAK8060
U.S. Govt. ID: NCT02061800
Contact: Desmarie Sherwood: 212-305-7213 / ds3851@cumc.columbia.edu
Additional Study Information: The purpose of this study is to determine the incidence and severity of acute GVHD following CD34+ selection in children, adolescents and young adults receiving an allogeneic peripheral blood stem cell transplant from a family member or unrelated adult donor for a malignant condition.
This study is closed
Investigator
Diane George, MD
Do You Qualify?
Are you less than 22 years of age? Yes No
Do you have a malignant disorder such as CML, AML, MDS, JMML, ALL or lymphoma? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cancel
For more information, please contact:
Desmarie Sherwood
ds3851@cumc.columbia.edu
212-305-7213
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE